135 related articles for article (PubMed ID: 37012339)
21. The Biology and Application Areas of CRISPR Technologies.
Adli M
J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
[No Abstract] [Full Text] [Related]
22. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
23. CRISPR Cinema: Scenes from the Cutting Edge.
Klotz C
CRISPR J; 2019 Apr; 2():76-78. PubMed ID: 30998095
[No Abstract] [Full Text] [Related]
24. CRISPR-Cas9 System: Opportunities and Concerns.
Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
[No Abstract] [Full Text] [Related]
25. Adaptation in CRISPR-Cas Systems.
Sternberg SH; Richter H; Charpentier E; Qimron U
Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
[TBL] [Abstract][Full Text] [Related]
26. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
28. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
Bradde S; Mora T; Walczak AM
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
[TBL] [Abstract][Full Text] [Related]
29. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.
Burmistrz M; Rodriguez Martinez JI; Krochmal D; Staniec D; Pyrc K
J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28893837
[TBL] [Abstract][Full Text] [Related]
30. Henceforth CRISPR.
Nat Biomed Eng; 2020 Nov; 4(11):1023. PubMed ID: 33060800
[TBL] [Abstract][Full Text] [Related]
31. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
32. [Not Available].
Nau JY
Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
[No Abstract] [Full Text] [Related]
33. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.
Smith C; Gore A; Yan W; Abalde-Atristain L; Li Z; He C; Wang Y; Brodsky RA; Zhang K; Cheng L; Ye Z
Cell Stem Cell; 2014 Jul; 15(1):12-3. PubMed ID: 24996165
[No Abstract] [Full Text] [Related]
34. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year.
Barrangou R
CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348
[No Abstract] [Full Text] [Related]
35. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
36. The CRISPR children.
Marx V
Nat Biotechnol; 2021 Dec; 39(12):1486-1490. PubMed ID: 34819659
[No Abstract] [Full Text] [Related]
37. CRISPR systems go mini.
Koch L
Nat Rev Genet; 2021 Nov; 22(11):690. PubMed ID: 34522033
[No Abstract] [Full Text] [Related]
38. Black Swans of CRISPR: Stochasticity and Complexity of Genetic Regulation.
Cheong KH; Koh JM; Jones MC
Bioessays; 2019 Jul; 41(7):e1900032. PubMed ID: 31090950
[TBL] [Abstract][Full Text] [Related]
39. [From the bacterial CRISPR locus, an adaptative immune system equivalent, to a universal editing tool].
Friot A; Dekeyzer B; Guingand A; Guguin J; Joly A; Vuillier S
Med Sci (Paris); 2018 May; 34(5):395-396. PubMed ID: 29900837
[No Abstract] [Full Text] [Related]
40. CRISPR gets crunchy.
Kling J
Lab Anim (NY); 2021 Jan; 50(1):9-11. PubMed ID: 33288962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
